Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT07228689

AI for Onsite Cytology Evaluation in Endoscopic Ultrasound

Conditions: Gastrointestinal Neoplasm, Mass Lesion

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 136

Sponsor: Orlando Health, Inc.

Location: Orlando Health Digestive Health Institute Orlando Florida

Summary

The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.

Eligibility Criteria

Inclusion Criteria: * Age 18 years old or greater * Patients undergoing EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract Exclusion Criteria: * Age less than 18 years * Patients not undergoing sampling of solid mass lesions at EUS * Patients with cystic lesions in the gastrointestinal tract

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07228689). StuddyBuddy aggregates publicly available trial information.